Spectrum Therapeutics, the medical division of Canopy Growth Corporation 
("Canopy Growth") (TSX: WEED ( 
https://www.newswire.ca/news-releases/spectrum-therapeutics-announces-strategic-patient-support-and-education-partnership-with-medical-pharmacies-878343953.html#financial-modal 
)) (NYSE: CGC) is pleased to announce that it has partnered with Tree of 
Knowledge International Corp. ("Tree of Knowledge") (CSE: TOKI) (OTC: TOKIF) to 
provide education and support for patients and their healthcare professionals 
working within the Tree of Knowledge healthcare network across Canada.
 
Photo - 
https://mma.prnewswire.com/media/1019834/Spectrum_Therapeutics_Spectrum_Therapeutics_and_Tree_of_Knowledg.jpg

 
As part of the two year agreement, Spectrum Therapeutics will collaborate with 
Tree of Knowledge's partner clinic, Jack Nathan Health, to launch several 
e-learning modules on its online education platform for healthcare 
professionals practicing in Jack Nathan clinics. In addition, Spectrum 
Therapeutics will host live webinars presented by leading Canadian experts on 
medical cannabis including: Dr. Kevin Rod, director of Toronto Poly Clinic 
multidisciplinary pain management clinics and Tree of Knowledge's Chief Medical 
Officer; Canopy Growth's Chief Medical Officer, Dr. Mark Ware and its Director 
of Global Medical Services, Dr. Danial Schecter. Topics that will be covered 
include an overview of medical cannabis and best practices for prescribing and 
dosing as well as chronic pain management and opioid reduction. 

Through its partnership with Jack Nathan Health, Tree of Knowledge will offer 
Chronic Pain Management and Medical Cannabis education programs in Jack Nathan 
clinics, which are located in 74 Walmart stores across six Canadian provinces 
and, on a combined basis, have more than 1.5 million patient visits annually. 
Jack Nathan Health also has six clinic locations in Mexico which are ideally 
positioned to support the opening of the Mexican medical cannabis market while 
leveraging Spectrum Therapeutics' global expertise in patient and physician 
education.

"Continuing to invest in training and education programs remains a priority for 
us as a gap in knowledge still exists for many healthcare professionals when it 
comes to medical cannabis," comments Dr. Mark Ware, Chief Medical Officer, 
Canopy Growth. "By partnering with Tree of Knowledge we're able to deliver 
these initiatives at scale which will provide more patients with access to 
knowledge on the potential of cannabis to address their needs with the guidance 
of a doctor." 

Spectrum Therapeutics and Tree of Knowledge will also work together on patient 
education including an animated video series and a customized patient dosing 
diary. Education programs will focus on topics like multidisciplinary pain 
management and opioid reduction programs. 

"The need for patient and provider cannabis education has grown substantially 
since legalization one year ago," said Michael Caridi, Chairman of Tree of 
Knowledge. "This strategic partnership with a global leader like Spectrum 
Therapeutics places focus squarely on educating patients in a medical setting. 
This partnership will launch targeted educational campaigns for patients in 
addition to providing training and support to their health care providers."

About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, 
hemp and cannabis device company, offering distinct brands and curated cannabis 
varieties in dried, oil and Softgel capsule forms, as well as medical devices 
through Canopy Growth's subsidiary, Storz & Bickel GMbH & Co. KG. From product 
and process innovation to market execution, Canopy Growth is driven by a 
passion for leadership and a commitment to building a world-class cannabis 
company one product, site and country at a time. Canopy Growth has operations 
in over a dozen countries across five continents.

Canopy Growth's medical division, Spectrum Therapeutics is proudly dedicated to 
educating healthcare practitioners, conducting robust clinical research, and 
furthering the public's understanding of cannabis, and has devoted millions of 
dollars toward cutting edge, commercializable research and IP development. 
Spectrum Therapeutics sells a range of full-spectrum products using its 
colour-coded classification Spectrum system as well as single cannabinoid 
Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across Canada under its award-winning 
Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand 
which has built a large and loyal following by focusing on quality products and 
meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York 
Stock Exchange to our continued international expansion, pride in advancing 
shareholder value through leadership is engrained in all we do at Canopy 
Growth. Canopy Growth has established partnerships with leading sector names 
including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA 
Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation 
Brands, to name but a few. Canopy Growth operates eleven licensed cannabis 
production sites with over 10.5 million square feet of production capacity, 
including over one million square feet of GMP certified production space. For 
more information visit www.canopygrowth.com

About Spectrum Therapeutics
Spectrum Therapeutics, the medical division of Canopy Growth Corporation (TSX: 
WEED, NYSE: CGC), is dedicated to educating healthcare practitioners, 
furthering the public's understanding of medical cannabis and its various 
applications, and cutting edge, commercializable research and IP development. 
Founded in Canada, Spectrum Therapeutics operates in Australia, South America, 
Africa and across Europe. Its products are available in a wide range of 
potencies and formats designed to simplify the dialogue around strength and 
dosage by applying a colour-coded spectrum to categorize medical cannabis 
according to THC and CBD levels. 

Spectrum Therapeutics' offerings include whole flower cannabis, oils and new 
innovations such as Softgels in addition to single cannabinoid medicine 
Dronabinol under the brand Bionorica Ethics. Through product simplification, 
robust clinical research and ongoing education of healthcare professionals, 
Spectrum Therapeutics is committed to addressing the unmet medical needs of 
patients around the globe.

About Tree of Knowledge
With its head office in Toronto, and operations in North York, Ontario and 
Spokane, Washington, TOKI currently has three primary business segments: (1) 
Multidisciplinary specialty pain clinics with a focus on the treatment of 
chronic pain, including controlled applications of medical cannabis in Canada, 
(2) Development of formulated products for therapeutic purposes and natural 
health product alternatives at its manufacturing facility in Spokane, which 
provides formulations for the Company's products and for third parties 
equivalent to GMP standards, and (3) Distribution and sale of hemp-based 
cannabidiol ("CBD") products in the United States, Canada, Europe, Brazil and 
Australia. Through its Toronto Poly Clinic, the Company has gleaned extensive 
expertise from being involved in one of the largest observational clinical 
trials on medical cannabis and from its ongoing direct patient experience. The 
Company has developed and implemented MCERP (Medical Cannabis Education, 
Research and Best Practice Platform) and MCORP (Medical Cannabis Opioid 
Reduction Program) with great success. Currently, the Company has research 
agreements with multiple universities for medical cannabis research and new 
medical grade products development. TOKI's CBD product line contains EVR 
Premium Hemp Oil, which is an organically grown and handled, gluten-free, 
vegan, non-GMO, synergistic compound that is derived from U.S. Department of 
Agriculture (USDA) approved industrial hemp grown in the United States. TOKI 
currently offers several CBD products, which may be used in connection with the 
treatment of a number of ailments and for general wellness purposes. 
https://www.tokicorp.com/

About Jack Nathan Health(R) 
Jack Nathan Health(R) is a privately owned and operated Canadian company—and a 
proud partner of Walmart Canada—dedicated to improving access to healthcare by 
partnering with highly-qualified medical professionals and delivering 
consistent, easy-access, patient-centric quality care in state-of-the-art 
medical and dental clinics conveniently located inside Walmart Supercenters, 
with 70-plus locations across Canada. Clinics are independently owned and 
operated under license by Jack Nathan Medical Inc., and not affiliated with 
Walmart.  Jack Nathan Health(R) is a registered trade-mark of Jack Nathan 
Medical Inc. All representations contained herein are made solely by Jack 
Nathan Health(R) or its licensed owner operators, and not independently 
verified by Walmart. All Walmart trademarks are the property of Wal-Mart 
Stores, Inc. and are used under license.
For more information, virtual clinic tours, and social media links, visit 
www.jacknathanhealth.com.

Notice Regarding Forward Looking Statements
This news release contains "forward-looking statements" within the meaning of 
the United States Private Securities Litigation Reform Act of 1995 and 
"forward-looking information" within the meaning of applicable Canadian 
securities legislation. Often, but not always, forward-looking statements and 
information can be identified by the use of words such as "plans", "expects" or 
"does not expect", "is expected", "estimates", "intends", "anticipates" or 
"does not anticipate", or "believes", or variations of such words and phrases 
or state that certain actions, events or results "may", "could", "would", 
"might" or "will" be taken, occur or be achieved. Forward-looking statements or 
information involve known and unknown risks, uncertainties and other factors 
which may cause the actual results, performance or achievements of Canopy 
Growth or its subsidiaries to be materially different from any future results, 
performance or achievements expressed or implied by the forward-looking 
statements or information contained in this news release. Examples of such 
statements include "will host live webinars presented by leading Canadian 
experts on medical cannabis" and "will also work together on patient education 
including an animated video series and a customized patient dosing diary". 
Risks, uncertainties and other factors involved with forward-looking 
information could cause actual events, results, performance, prospects and 
opportunities to differ materially from those expressed or implied by such 
forward-looking information, including the development and delivery of 
educational content, and such risks contained in the Company's annual 
information form dated June 25, 2019 and filed with Canadian securities 
regulators available on the Company's issuer profile on SEDAR at www.sedar.com. 
Although the Company believes that the assumptions and factors used in 
preparing the forward-looking information or forward-looking statements in this 
news release are reasonable, undue reliance should not be placed on such 
information and no assurance can be given that such events will occur in the 
disclosed time frames or at all. The forward-looking information and 
forward-looking statements included in this news release are made as of the 
date of this news release and the Company does not undertake an obligation to 
publicly update such forward-looking information or forward-looking information 
to reflect new information, subsequent events or otherwise unless required by 
applicable securities laws.

For further information: Canopy Growth, Carly Pickett, Media Relations, 
carly.pickett@canopygrowth.com, 343-996-3234; Tyler Burns, Investor Relations, 
Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Tree of Knowledge 
International Corp., Natasha Raey, Media Relations, Natasha@tokicorp.com, 
778-552-4538; Michael Caridi, Chairman, Michael@tokicorp.com, 917-295-1374

Source - Spectrum Therapeutics